References and Notes
For reviews, see:
<A NAME="RD13009ST-1A">1a</A>
Vaillancourt V.
Pratt NE.
Perron F.
Albizati KF.
The Total Synthesis of Spiroketal-Containing
Natural Products, In Total Synthesis
of Natural Compounds
Vol. 8:
ApSimon J.
John Wiley and Sons;
New
York:
2007.
<A NAME="RD13009ST-1B">1b</A>
Aho JE.
Pihko PM.
Rissa TK.
Chem.
Rev.
2005,
105:
4406
<A NAME="RD13009ST-2">2</A>
Ueno T.
Takahashi H.
Oda M.
Mizunuma M.
Yokoyama A.
Goto Y.
Mizushina M.
Sakaguchi K.
Hayashi H.
Biochemistry
2000,
39:
5995
<A NAME="RD13009ST-3">3</A>
Stierle AA.
Stierle DB.
Kelly K.
J.
Org. Chem.
2006,
71:
5357
<A NAME="RD13009ST-4">4</A>
Fujimoto H.
Nozawa M.
Okuyama E.
Ishibashi M.
Chem. Pharm. Bull.
2002,
50:
330
<A NAME="RD13009ST-5">5</A>
Buchgraber P.
Snaddon TN.
Wirtz C.
Mynott R.
Goddard R.
Fürstner A.
Angew. Chem. Int.
Ed.
2008,
47:
8450
<A NAME="RD13009ST-6">6</A>
Wu X.
Zhou J.
Snider BB.
Angew.
Chem. Int. Ed.
2009,
48:
1283
<A NAME="RD13009ST-7">7</A>
Bray CD.
Org.
Biomol. Chem.
2008,
6:
2815
<A NAME="RD13009ST-8">8</A>
Barluenga J.
Mendoza A.
Rodríguez F.
Fañanás FJ.
Angew.
Chem. Int. Ed.
2009,
48:
1644
<A NAME="RD13009ST-9">9</A>
Liu Y.-C.
Sperry J.
Rathwell DC.
Brimble MA.
Synlett
2009,
793
<A NAME="RD13009ST-10">10</A>
Kulinkovich OG.
Sviridov SV.
Vasilevski DA.
Pritytskaya TS.
J.
Org. Chem. USSR (Engl. Transl.)
1989,
25:
2027; Zh. Org. Khim. 1989, 25, 2244
<A NAME="RD13009ST-11">11</A>
Kulinkovich OG.
Sviridov SV.
Vasilevski DA.
Savchenko AI.
Pritytskaya TS.
J. Org. Chem. USSR (Engl. Transl.)
1991,
27:
250 ; Zh. Org. Khim. 1991, 27, 294
<A NAME="RD13009ST-12A">12a</A>
Lee J.
Kang CH.
Kim H.
Cha JK.
J.
Am. Chem. Soc.
1996,
118:
291
<A NAME="RD13009ST-12B">12b</A>
Lee J.
Kim H.
Cha J.
J.
Am. Chem. Soc.
1996,
118:
4198
<A NAME="RD13009ST-13">13</A>
Kasatkin A.
Sato F.
Tetrahedron Lett.
1995,
36:
6079
<A NAME="RD13009ST-14">14</A>
Kulinkovich OG.
Epstein OL.
Savchenko AI.
Tetrahedron Lett.
1999,
40:
5935
<A NAME="RD13009ST-15">15</A>
Keaton KA.
Phillips AJ.
Org. Lett.
2007,
9:
2717
<A NAME="RD13009ST-16">16</A>
Keaton KA.
Phillips AJ.
Org. Lett.
2008,
10:
1083
<A NAME="RD13009ST-17">17</A>
Gollner A.
Mulzer J.
Org. Lett.
2008,
10:
4701
<A NAME="RD13009ST-18">18</A>
Esposito A.
Taddei M.
J. Org. Chem.
2000,
65:
9245
<A NAME="RD13009ST-19">19</A>
Eisch JJ.
Adeosun AA.
Gitua JN.
Eur. J. Org. Chem.
2003,
4721
<A NAME="RD13009ST-20">20</A>
Marsault E.
Hoveyda HR.
Peterson ML.
Saint-Louis C.
Landry A.
Vézina M.
Oullet L.
Wang Z.
Ramaseshan M.
Beaubien S.
Benakli K.
Beauchemin S.
Déziel R.
Peeters T.
Fraser GL.
J. Med. Chem.
2006,
49:
7190
<A NAME="RD13009ST-21">21</A>
Bruijnincx PCA.
Lutz M.
Spek AL.
Hagen WR.
van Koten G.
Klein Gebinnk RJM.
Inorg. Chem.
2007,
46:
8391
<A NAME="RD13009ST-22">22</A>
Cordoba R.
Tormo NS.
Medarde AF.
Plumet J.
Bioorg. Med.
Chem.
2007,
15:
5300
<A NAME="RD13009ST-23A">23a</A>
DePuy CH.
Van Lanen RJ.
J. Org. Chem.
1974,
29:
3360
<A NAME="RD13009ST-23B">23b</A>
DePuy CH.
Breitbeil FW.
DeBruin KR.
J. Am. Chem. Soc.
1966,
88:
3347
<A NAME="RD13009ST-24">24</A>
Waters SP.
Fennie MW.
Kozlowski MC.
Tetrahedron Lett.
2006,
47:
5409
<A NAME="RD13009ST-25">25</A>
General Procedure - Kulinkovich
Reaction
A solution of Ti(Oi-Pr)4 (2.16
mmol) in THF (5 mL) was cooled to an internal temperature of -40 ˚C. c-C6H11MgCl (6.49
mmol) was added at such a rate that the internal temperature did
not exceed -35 ˚C. Styrene (0.72 mmol) was
added and the orange-brown suspension stirred for 2 h at -35 ˚C.
Ester (0.72 mmol) was added and the suspension warmed to r.t. whereupon
a brown color developed. After stirring for 1 h, the suspension
was diluted with EtOAc (75 mL) and poured into sat. NH4Cl
solution (75 mL). The emulsion was stirred vigorously for 30 min
then filtered through a pad of Celite®. The
aqueous layer was extracted with EtOAc (3 × 75
mL), then the combined organic phases were dried over MgSO4,
filtered, and the solvent removed in vacuo. The crude product was
purified by flash chromatog-raphy (hexane-EtOAc, 2:1) to
afford the cyclopropanol.
1-[3-(Benzyloxy)propyl]-2-[2-(ethoxymethoxy)-4-methoxyphenyl]cyclopropanol (21)
Yellow oil. R
f
= 0.23
(hexane-EtOAc, 2:1). IR (film): ν = 3440,
2928, 1711, 1610, 1505, 1453, 1360, 1279, 1254, 1199, 1156, 1100,
1075, 996, 842, 736, 689 cm-¹. ¹H
NMR (300 MHz, CDCl3): δ = 0.89
(dd, J = 7.3,
5.7 Hz, 1 H, H-2), 1.12-1.29 (m, 4 H, CH3, H-3),
1.56 (dd, J = 14.4,
7.4 Hz, 2 H, H-1′), 1.70 (quin, J = 6.3
Hz, 2 H, H-2′), 2.30 (dd, J = 9.9, 7.3
Hz, 1 H, H-3), 3.48 (t, J = 5.8
Hz, 2 H, H-3′), 3.74 (q, J = 7.1
Hz, 2 H, OCH
2CH3),
3.78 (s, 3 H, OMe), 4.47 (s, 2 H, OCH2Ph), 5.25 (q, J = 6.3 Hz,
2 H, OCH2O), 6.45 (dd, J = 8.4,
2.5 Hz, 1 H, H-5′), 6.73 (d, J = 2.5
Hz, 1 H, H-3′), 6.79 (d, J = 8.4
Hz, 1 H, H-6′), 7.27-7.34 (m, 5 H, OBn). ¹³C NMR
(75 MHz, CDCl3): δ = 15.1
(CH3), 17.1 (CH2, C-3), 25.9 (CH2,
C-2′), 26.1 (CH, C-2), 31.4 (CH2, C-1′),
55.3 (CH3, OMe), 64.2 (q, C-1), 70.7 (CH2,
OCH2CH3), 72.9 (CH2,
OCH2Ph), 93.4 (CH2, OCH2O), 101.4
(CH, C-4′′), 105.6 (CH, C-5′′),
127.6 (CH, C-6′′), 127.7 (CH, C-2′′′,
C-6′′′),
128.2 (CH, C-4′′′), 128.4 (CH, C-3′′′,
C-5′′′), 148.7 (q, C-1′′,
C-1′′′), 159.0 (q, C-2′′,
C-3′′). MS (EI, 70eV):
m/z (%) = 247
(16), 409 (100) [M+ + Na],
793 (2 M+ + Na]. HRMS (EI): m/z [M+ + Na] calcd
for C23H30NaO5: 409.1991; found:
409.1985.
<A NAME="RD13009ST-26">26</A>
General Procedure - Ring
Opening of Cyclopropanols
Cyclopropanol (0.34 mmol)
was added to dioxane (3 mL) and 0.2 N NaOH solution (6 mL). The
reaction was stirred at reflux for 3 d, then neutralized to pH 7
with 2 M HCl. The aqueous layer was extracted with Et2O
(5 × 10 mL). The combined organic layers
were dried over MgSO4, filtered, and the solvent removed
in vacuo. The crude product was purified by flash chromatography
(hexane-EtOAc, 4:1) to afford the ketone.
6-(Benzyloxy)-1-[2-(ethoxymethoxy)-4-methoxy-phenyl]hexan-3-one (26)
Yellow oil. R
f
= 0.38
(hexane-EtOAc, 4:1). IR (film): ν = 2927,
1712, 1610, 1587, 1506, 1444, 1361, 1284, 1256, 1199, 1154, 1100,
1077, 997, 842, 737, 698 cm-¹. ¹H
NMR (300 MHz, CDCl3): δ = 1.22
(t, J = 7.1
Hz, 3 H, OCH2CH
3), 1.88
(quin, J = 6.7
Hz, 2 H, H-5), 2.50 (t, J = 7.3
Hz, 2 H, H-4), 2.66 (t, J
A,B = 7.7
Hz, 2 H, H-2), 2.81 (t, J
A,B = 7.4
Hz, 2 H, H-1), 3.46 (t, J = 6.4
Hz, 2 H, H-6), 3.71 (q, J = 7.0
Hz, 2 H, OCH
2CH3),
3.77 (s, 3 H, OMe), 4.47 (s, 2 H, OCH2Ph), 5.22 (s, 2
H, OCH2O), 6.46 (dd, J = 8.3,
2.6 Hz, 1 H, H-5′), 6.70 (d, J = 2.5
Hz, 1 H, H-3′), 7.01 (d, J = 8.0
Hz, 1 H, H-6′). ¹³C NMR (75
MHz, CDCl3): δ = 15.1
(CH3), 23.8 (CH2, C-5), 24.3 (CH2,
C-1), 39.4 (CH2, C-4), 43.2 (CH2, C-2), 55.3
(CH3, OMe), 64.3 (CH2, OCH2CH3),
69.4 (CH2, C-6), 72.8 (CH2, OCH2Ph),
93.1 (CH2, OCH2O), 101.4 (CH, C-3′), 105.8
(CH, C-5′), 127.5 (CH, C-4′′), 127.6
(CH, 2′′, C-6), 128.4 (CH, C-3′′,
C-5′′), 130.1 (q, C-1′), 130.2 (CH, C-6′), 138.7.9
(q, C-1′′), 156.0 (q, C-2′), 159.2 (q,
C-4′), 210.8 (q, C-3). MS (EI, 70eV): m/z (%) = 97
(19), 151 (55), 177 (82), 207 (27), 235 (67), 253 (19), 275 (17),
311 (46), 341 (31), 385 (5) [M+],
409 (100) [M+ + Na].
HRMS (EI): m/z [M+ + Na] calcd
for C23H30NaO5: 409.1991; found:
409.1985.